Scientific Advisory

External clinical guidance

Our medical strategy is reviewed by an external panel of practising clinicians and senior pharmacists. The panel does not participate in commercial decisions; its role is to test whether our claims, educational material and portfolio priorities reflect current clinical practice.

What the panel reviews

• Prescribing information and product summaries before publication.
• Educational material issued to healthcare professionals.
• Portfolio gaps in the therapeutic areas we serve.
• Pharmacovigilance and risk-minimisation priorities.

Independence

All panel members declare potential conflicts of interest annually, including any financial relationship with Sanveex or its manufacturing partners. Members are not compensated for endorsing specific products, and any opinion recorded against a proposal is documented in the medical affairs file.